Multiplexed Comparative Analysis of Intact Glycopeptides Using Electron-Transfer Dissociation and Synchronous Precursor Selection Based Triple-Stage Mass Spectrometry

• Published in: Analytical chemistry (Washington) 2020-06, Vol.92 (11), p.7547-7555
• Main Authors: Zhu, Hongbin, Qiu, Chen, Gryniewicz-Ruzicka, Connie M, Keire, David A, Ye, Hongping
• Format: Article
• Language: English
• Subjects: Antibiotics; Chemistry; Comparative analysis; Electron Transport; Energy of dissociation; Fragmentation; Glucosylceramidase - metabolism; Glycopeptides; Glycopeptides - analysis; Glycopeptides - metabolism; Glycoproteins; Humans; Ions; Mass Spectrometry; Mass spectroscopy; Multiplexing; Optimization; Peptides; Polysaccharides; Precursors; Scientific imaging; Spectroscopy; Tandem Mass Spectrometry; Workflow
• ISSN: 0003-2700; 1520-6882
• DOI: 10.1021/acs.analchem.0c00014

A recently developed synchronous precursor selection (SPS) mass spectrometry to the third (MS3) protocol enables more accurate multiplexed quantification of proteins/peptides using tandem mass tags (TMT) through comparison of reporter ion intensities at the MS3 level. However, challenges still exist for TMT-based simultaneous quantification and identification of intact glycopeptides due to inefficient peptide backbone fragmentation when using collision-induced dissociation (CID). To overcome this limitation, here we report an improved SPS/ETD workflow for TMT-based intact glycopeptide quantification and identification. The SPS/ETD approach was implemented on an Orbitrap Tribrid mass spectrometer and begins with selection of a parent ion in the MS scan, followed by tandem mass spectrometry (MS2) fragmentation by CID in the ion trap. Following MS2 fragmentation, SPS enables simultaneous isolation of the top 10 MS2 fragment ions for further higher energy collisional dissociation (HCD) fragmentation with the resulting MS3 fragments detected in an Orbitrap analyzer. Here, in addition to the standard SPS workflow, an electron-transfer dissociation (ETD) MS2 was performed and analyzed in the ion trap. The resultant ETD and CID spectra were used for the identification of the intact glycopeptides, while the quantitative comparison of site-specific glycans was achieved utilizing TMT reporter ions from HCD MS3 spectra. For intact glycopeptides, through systematic optimization and evaluation using a glycoprotein interference model, the SPS/ETD approach was demonstrated to offer improved accuracy, precision, and sensitivity compared to traditional data-dependent MS2 quantification, while maintaining the glycopeptide identification capability. Finally, this workflow was applied for the site-specific quantitative comparison of the glycoforms for two therapeutic enzymes (Cerezyme and VPRIV) and their different lots. The results demonstrate that this workflow is suitable for TMT-based intact glycopeptide characterization of glycoproteins.